DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
55 hedge funds and large institutions have $79.7M invested in Dicerna Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less capital invested
Capital invested by funds: $185M → $79.7M (-$105M)
Holders
55
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$645K | |
| 2 | +$343K | |
| 3 | +$192K | |
| 4 |
Renaissance Technologies
New York
|
+$160K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$147K |
Top Sellers
| 1 | -$1.96M | |
| 2 | -$1.47M | |
| 3 | -$709K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$272K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$271K |